Telemedicine company Hims & Hers Health Inc. shares surged 37.9% in pre-market trading, showing exceptionally strong performance.
Show original
This significant surge was triggered by a market report indicating that pharmaceutical giant Novo Nordisk plans to sell its popular weight-loss drugs through the Hims & Hers Health platform. This move is seen as a major endorsement of Hims & Hers' business model and could open up a substantial new revenue stream for the company. Investors responded enthusiastically to the news, driving a sharp increase in the company's market value.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreLand & Buildings Investment Management released a statement, bluntly pointing out that the board of First Industrial Realty Trust is causing significant losses to shareholders due to its adherence to the status quo and lack of change, estimating a per-share value loss of up to approximately $15.
The US Department of Justice has reached a preliminary settlement with live entertainment giant Live Nation Entertainment regarding antitrust charges, and the details of the agreement have recently been submitted to the court for review.
Crypto prices
MoreBitcoin
BTC
$68,224.91
+1.67%
Ethereum
ETH
$2,002.06
+3.29%
Tether USDt
USDT
$1.0000
+0.00%
BNB
BNB
$632.23
+2.64%
XRP
XRP
$1.36
+0.60%
USDC
USDC
$1
+0.02%
Solana
SOL
$84.18
+2.79%
TRON
TRX
$0.2849
-0.59%
Dogecoin
DOGE
$0.09107
+2.84%
Cardano
ADA
$0.2557
+1.22%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now